Evidence map›Paper›PMID 32635946›Full record

ReviewEpidemiology and infection2020

Non-O1/non-O139

Xinyao Li, Yuanyuan Wu, Xiaojun Sun, Jianping Ma, Xiaofeng Li, Cuiping Liu, Hongxiang Xie

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Epidemiology and infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Septic shock caused by non-O1/non-O139World journal of emergency medicine · 2025
    Article
  9. Article
  10. Tropical medicine and infectious disease · 2024
    Article
  11. Article
  12. Non-O1, Non-O139Case reports in infectious diseases · 2024
    Article
  13. Article
  14. Case report: Detection of non-O1/non-O139Frontiers in medicine · 2024
    Article
  15. Whole Genome Sequencing of a Non-O1/O139-GroupInfection and drug resistance · 2024
    Article
  16. Review
  17. Article
  18. Whole Genome Analysis of a Non-O1, Non-O139Infection and drug resistance · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Xinyao LiDepartment of Cardiology, Zhejiang Hospital, Hangzhou, China.
Yuanyuan WuDepartment of Shungen Conservative and Endodontic Dentistry, Jinan Stomatology Hospital, Jinan, China.
Xiaojun SunDepartment of Clinical Laboratory, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Jianping MaDepartment of Clinical Laboratory, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Xiaofeng LiDepartment of Clinical Laboratory, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Cuiping LiuDepartment of General Medicine, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
Hongxiang XieDepartment of Clinical Laboratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.ORCID 0000-0001-6737-0493
Shandong First Medical University · CNZhejiang Hospital · CNStomatology Hospital · CNZhejiang Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In mainland China, the clinical, epidemiological and genetic features of non-O1/non-O139 Vibrio cholerae (NOVC) bacteraemia have been scarcely investigated. Herein, we describe a patient with NOVC bacteraemia diagnosed in our hospital and present a retrospective analysis of literature reports of 32 other cases in China, detailing the clinical epidemiology, antibiotic resistance and molecular characteristics of isolates. Most patients were male (84.8%; median age, 53 years) and had predisposing factors, such as cirrhosis, malignant tumours, blood diseases and diabetes. In addition to fever, gastroenteritis was the most frequent presenting symptom. The mortality rate during hospitalisation was 12.1%. NOVC bacteraemia cases were more common in June-August, with the majority in coastal provinces and the Yangtze River basin. Only 42.4% of cases were attributed to consumption of marine (aquatic) products. Tetracycline, third-generation cephalosporins, and fluoroquinolones were the most effective antimicrobial agents, and the highest frequencies of resistance were recorded for ampicillin/sulbactam (37.5%), amoxicillin/clavulanic acid (33.3%), ampicillin (29.2%) and sulfamethoxazole (20%). Multi-drug resistant isolates were not detected. Limited data indicate that ctxAB and tcpA genes were absent in all NOVC isolates but other putative virulence genes (hlyA, toxR, hap and rtxA) were common. Ten multilocus sequence types were identified with marked genetic heterogeneity between different isolates. As clinical manifestations of NOVC bacteraemia may vary widely, and isolates exhibit genetic diversity, clinicians and public health experts should be alerted to the possibility of infection with this pathogen because of the high prevalence of liver disease in China.

Indexed as

Vibrio choleraeAgedAnti-Bacterial AgentsBacteremiaChinaCholeraHumansMaleAnti-Bacterial Agentsantimicrobial resistancebacteraemiaChinacirrhosisnon-O1/non-O139 Vibrio cholerae

Identifiers

PMID32635946
PMCPMC7482189
OpenAlexW3041861739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.